{"url_path":"/sec/dgx/8-k/2026-01-12/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-01-12","source_url":"https://www.sec.gov/Archives/edgar/data/1022079/0000947871-26-000025-index.html","accession_number":"0000947871-26-000025","cik":"0001022079","ticker":"DGX","issuer_name":"QUEST DIAGNOSTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022079/0000947871-26-000025-index.html","primary_entity_key":"0001022079","primary_entity_name":"QUEST DIAGNOSTICS INC"},"word_count":379,"has_tables":true,"body_markdown":"**Item 7.01. Regulation FD Disclosure**\n\n \n\nOn January 12, 2026, Quest Diagnostics Incorporated\n(the “Company”) will speak on the Company's strategy, performance, and the latest market developments and trends during a\npresentation and Q&A session at the 44th Annual J.P. Morgan Healthcare Conference (the “Conference”).\n\n \n\nA copy of the presentation materials to be used\nby the Company at the Conference are furnished as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated into this Item\n7.01 of this Current Report on Form 8-K by reference. The presentation materials include information regarding the matters discussed by\nthe Company at the Conference.\n\n \n\nThe information in the preceding paragraphs,\nas well as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as\namended (the “Exchange Act”), or otherwise subject to the liabilities of that section. It may only be incorporated by reference\ninto another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references\nthis Current Report on Form 8-K.\n\n \n\nThe statements in the presentation materials\nwhich are not historical facts may be forward-looking statements. Readers and others are cautioned not to place undue reliance on forward-looking\nstatements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations\nor beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and\nuncertainties that may affect the future results of the Company include, but are not limited to, uncertain and volatile economic conditions,\nadverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity\nof billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government policies, including related to\ntrade, and regulations, changing relationships with customers, payers, suppliers, or strategic partners, acquisitions, and other factors\ndiscussed in the Company's most recently filed Annual Report on Form 10-K and in any of the Company's subsequently filed Quarterly Reports\non Form 10-Q and Current Reports on Form 8-K, including those discussed in the \"Business,\" \"Risk Factors,\" \"Cautionary\nFactors that May Affect Future Results\" and \"Management's Discussion and Analysis of Financial Condition and Results of Operations\"\nsections of those reports."}